Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 261

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation

Brugada, Josep, Pappone, Carlo, Berruezo, Antonio, Vicedomini, Gabriele, Manguso, Francesco, Ciconte, Giuseppe, Giannelli, Luigi, Santinelli, Vincenzo·2015·Circulation: Arrhythmia and Electrophysiology

Abstract

Background—: Whether Brugada syndrome (BrS) depends on functional epicardial substrates, which may be definitively eliminated by radiofrequency ablation, remains unknown. Methods and Results—: Patients with BrS underwent epicardial mapping to identify areas of abnormal electrograms as target for radiofrequency ablation. Substrate identification consisted in mapping right ventricle epicardial surface before and after flecainide (2 mg/kg per 10 minutes). After radiofrequency ablation, flecainide and remap confirmed elimination of abnormal substrate, BrS ECG pattern, and ventricular tachycardia/ventricular fibrillation inducibility. Flecainide testing was performed at each follow-up visits ≤6 months. Fourteen patients with BrS, median age 39 years (30.3–42.3) with implantable cardioverter–defibrillator were enrolled. Low-voltage areas (<1.5 mV) were commonly identified on the anterior right free wall and right ventricular outflow tract, which increased after flecainide from 17.6 cm 2 (12.1–24.2) to 28.5 cm 2 (21.6–30.2; P =0.001). Similarly, areas with abnormal electrograms increased after flecainide from 19.0 (17.5–23.6) to 27.3 cm 2 (24.0–31.2; P =0.001). After 23.8 minutes (18.1–28.5) of radiofrequency ablation, abnormal electrograms disappeared, whereas low-voltage areas were replaced by scar areas (<0.5 mV) of 25.9 cm 2 (19.6–31.0). Substrate elimination resulted in BrS ECG pattern disappearance and no ventricular tachycardia/ventricular fibrillation inducibility without complications. After a median follow-up of 5 months (3.8–5.3), ECG remained normal despite flecainide. Conclusions—: In patients with BrS, there is a relationship between abnormal ECG pattern, the extent of abnormal epicardial substrate, and ventricular tachycardia/ventricular fibrillation inducibility. Ablation of the substrate identified in the presence of flecainide can eliminate the BrS phenotype and warrants further study.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circep.115.003220

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 261

Metadata

Authors
Brugada, J., Pappone, C., Berruezo, A., Vicedomini, G., Manguso, F., Ciconte, G., Giannelli, L., & Santinelli, V.
Venue
Circulation: Arrhythmia and Electrophysiology
Published
2015-12
Volume
8
Issue
6
Pages
1373-1381
ISSN
  • 1941-3084 (ISSN-L)
  • 1941-3149
OpenAlex
W2098526943
Cited by
261
References
10
FWCI
24.76
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation. https://app.cochat.ai/papers/10.1161/circep.115.003220
The paper
Brugada, J., Pappone, C., Berruezo, A., Vicedomini, G., Manguso, F., Ciconte, G., Giannelli, L., & Santinelli, V. (2015). Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation. Circulation: Arrhythmia and Electrophysiology. https://doi.org/10.1161/circep.115.003220

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.